COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA : Invitation to presentation of first quarter 2018 results

09/05/2018 - 08:30

Oslo, 09 May 2018 - Solon Eiendom ASA will publish its first quarter 2018 results on Wednesday 16 May at 08.00 am CET. The quarterly report and the presentation will be available on the company's web site, www. [...]

Bone Therapeutics SA : The preliminary documents for the Annual Ordinary and the Extraordinary General Shareholder Meeting on 13 June 2018 have been made available

09/05/2018 - 08:01

Regulated information The preliminary documents for the Annual Ordinary and the Extraordinary General Shareholder Meeting on 13 June 2018 have been made available Gosselies, Belgium, 9 May 2018, 8am CEST - BONE [...]

Bone Therapeutics SA : Mise à disposition des documents préparatoires à l'assemblée générale ordinaire et à l'assemblée générale extraordinaire du 13 juin 2018

09/05/2018 - 08:01

Information réglementée Mise à disposition des documents préparatoires à l'assemblée générale ordinaire et à l'assemblée générale extraordinaire du 13 juin 2018 Gosselies, Belgique, le 9 mai 2018, 8h00 CEST - BONE [...]

Shire plc : Rule 2.9 Announcement

09/05/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 9 May 2018 Shire [...]

Motif Bio Appoints Stephanie Noviello, MD, MPH as Vice President, Clinical Development

09/05/2018 - 08:00

NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that Stephanie Noviello, MD, [...]

ThromboGenics Business Update - Q1 2018

09/05/2018 - 07:31

Press release 9 May 2018 Regulated Information Advancing Diabetic Eye Disease Portfolio Positive Initial Topline Data from Phase 1/ 2a Clinical Study evaluating THR-317, anti-PlGF, for the Treatment of Diabetic Macular [...]

ERYTECH to Host First Quarter 2018 Conference Call and Business Update

09/05/2018 - 07:30

LYON, France, May 09, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]

Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018

09/05/2018 - 07:02

Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018 Amsterdam, the Netherlands, Holzgerlingen, Germany and San Diego, CA, USA, May 9, 2018, 07:00 am CEST / 01:00 am EDT - Curetis N.V. (the " Company " [...]

IBA SA : IBA Business Update - First Quarter 2018

09/05/2018 - 07:01

IBA Business Update - First Quarter 2018 21 ongoing proton therapy projects in 2018 Louvain-La-Neuve, Belgium, 9 May 2018 - IBA (Ion Beam Applications S.A., EURONEXT), the world's leading provider of proton therapy [...]

IBA SA : IBA Déclaration Intermédiaire - Premier Trimestre 2018

09/05/2018 - 07:01

IBA Déclaration Intermédiaire - Premier Trimestre 2018 21 projets de protonthérapie en cours d'installation en 2018 Louvain-La-Neuve, Belgique, 9 mai 2018 - IBA ( Ion Beam Applications SA , EURONEXT), le premier [...]

argenx reports first quarter 2018 financial results and provides business update

09/05/2018 - 07:00

May 9, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment [...]

Medibio Corporate Health contract signed with Australia’s 3rd largest private healthcare provider

09/05/2018 - 06:00

SYDNEY, Australia and MINNEAPOLIS, May 08, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced the execution of a commercial [...]

Evelo Biosciences Announces Pricing of Initial Public Offering

09/05/2018 - 01:29

CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO ) (“Evelo”) today announced the pricing of its initial public offering of 5,312,500 shares of common stock at a public offering [...]

MediciNova to Present at the UBS Global Healthcare Conference in New York

09/05/2018 - 01:00

LA JOLLA, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]

IntelGenx Closes Private Placement Financing

08/05/2018 - 23:24

SAINT LAURENT, Quebec, May 08, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX ) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces the closing of the previously announced offering by way of private [...]

Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update

08/05/2018 - 23:04

Conference Call and Webcast on Wednesday, May 9 at 8:30am Eastern Time REHOVOT, Israel, May 08, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ) (“Foamix” or the “Company”), a clinical stage [...]

Reata Pharmaceuticals, Inc. Announces First Quarter 2018 Financial Results and an Update on Development Programs

08/05/2018 - 23:00

CATALYST TRIAL IN CTD-PAH FINAL SAMPLE SIZE SET AT 200; TOP-LINE DATA EXPECTED IN THE FIRST HALF OF 2020 PHOENIX TRIAL INTERIM DATA FOR ADPKD AND IGA NEPHROPATHY COHORTS AT ERA-EDTA IN MAY; FULL DATA FOR THESE COHORTS [...]

Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore

08/05/2018 - 23:00

MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year [...]

Emblem Announces Settlement With Dissenting Shareholder

08/05/2018 - 22:44

TORONTO, May 08, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (" Emblem " or the " Corporation ") announces that it has agreed to issue an aggregate of 482,758 common shares in the capital of Emblem (the “ [...]